Evidence map›Paper›PMID 41295253›Full record

ReviewJournal of personalized medicine2025

Comparative Insights into Cutaneous, Mucosal, and Vulvovaginal Melanomas: Biology, Targeted Therapies, and Survival with a Focus on Immune Checkpoint Inhibitors.

Danielle Christmas, Christina Pappa, Catherine Howell, Mohammad Daas, Keith Howell, Sunanda Dhar, Binamra Sigdel, Sanjiv Manek, Moiad Alazzam

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of personalized medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Danielle ChristmasDepartment of Gynaecological Oncology, Oxford University Hospitals, NHS Foundation Trust, Oxford OX3 9LE, UK.
Christina PappaDepartment of Gynaecological Oncology, Oxford University Hospitals, NHS Foundation Trust, Oxford OX3 9LE, UK.ORCID 0000-0003-2801-2786
Catherine HowellGynaeFellow Research Collaborative, Old Road, Oxford OX3 7LE, UK.
Mohammad DaasGynaeFellow Research Collaborative, Old Road, Oxford OX3 7LE, UK.ORCID 0000-0001-7106-0834
Keith HowellLeeds Cancer Centre, St James's University Hospital, Leeds Teaching Hospitals, Beckett Street, Leeds LS9 7TF, UK.ORCID 0009-0009-3002-2079
Sunanda DharDepartment of Cellular Pathology, Oxford University Hospitals, NHS Foundation Trust, Oxford OX3 9LE, UK.ORCID 0000-0002-1885-6048
Binamra SigdelDepartment of Gynaecological Oncology, Oxford University Hospitals, NHS Foundation Trust, Oxford OX3 9LE, UK.ORCID 0000-0003-1485-8895
Sanjiv ManekDepartment of Cellular Pathology, Oxford University Hospitals, NHS Foundation Trust, Oxford OX3 9LE, UK.
Moiad AlazzamDepartment of Gynaecological Oncology, Oxford University Hospitals, NHS Foundation Trust, Oxford OX3 9LE, UK.ORCID 0000-0001-8202-0969

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BRAF mutationcutaneous melanomaimmunotherapymucosal melanomatargeted therapytumour microenvironmentvulvovaginal melanoma

Identifiers

PMID41295253
PMCPMC12653355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.